Index of Slides : Graphic Version 800x600
- No Title
- Prophylactics and Therapeutics
- NanoViricides Pendantized Polymeric Micelles based, Conformationally Flexible, Specifically Targeted Drugs > Regulatory Implications for (a) Normal IND-enabling Study, and (b) a Novel "War-like" Bio-threat Response Mechanism
- NanoViricides Approach
- NanoViricides Nano-Machines
- First Generation: Simple Products - No Encapsulation Covalently Attached Ligands to a Single Molecular Chain
- Antiviral Spectrum is Specified by Ligand Set
- Several Magnitudes Efficacy Improvement over Current Drugs with NanoViricides Ex: Influenzas, Comparative Efficacies (Putative Estimates)
- It is of Interest to Accelerate the Development of Highly Efficacious Antiviral Drugs such as Nanoviricides
- Future of our Approach
- NanoViricides Polymeric Micelles: Key Differences from Usual Drugs & Biologics: I. Characteristics
- NanoViricides Polymeric Micelles: Key Differences from Usual Drugs & Biologics: II. Limitations in Chemical Characterization
- NanoViricides Polymeric Micelles: Key Differences from Usual Drugs & Biologics: III. Limitations in Physical Characterization
- Polymeric Micelles: Precedence Closest Cases are Some Excipients
- SAFETY, EFFICACY, CMC Data and Studies A Balanced Approach is Needed to Speed up Development of Extremely High Efficacy Drugs such as NanoViricides
- Part II : “War-Like” Scenario- Unknown Agent - Bioterrorism or Natural - NanoViricides Enable Novel Public Health Approach
- Part II : “War-Like” Scenario- Unknown Agent - Bioterrorism or Natural - NanoViricides Enable Novel Public Health Approach
- Part II : “War-Like” Scenario- Unknown Agent - Bioterrorism or Natural - NanoViricides Enable Novel Public Health Approach
- No Title